Compared with Q1, the fully adjusted ORs were 0.20 for Q2 (95% CI 0.04–1.10; p = 0.062), 0.03 for Q3 (95% CI 0.01–0.29; p = 0.002), and 0.01 for Q4 (95% CI 0.01–0.39; p = 0.013), with a significant trend across quartiles ( P for trend = 0.003).
← all excerpts
How much is enough? Hematoma clearance thresholds and 30-day outcomes after sMIS for ICH across overall and baseline volume strata.
1
—
—